Evidence map›Paper›PMID 38091054›Full record

ArticleArchives of gynecology and obstetrics2024

Importance of a detailed anomaly scan after a cfDNA test indicating fetal trisomy 21, 18 or 13.

Tobias Spingler, Jiri Sonek, Markus Hoopmann, Natalia Prodan, Gertruda Jonaityte, Tania Elger, Karl Oliver Kagan

Open access · hybridAbstract read
In one paragraph

Article in Archives of gynecology and obstetrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Tobias SpinglerDepartment of Women's Health, University of Tuebingen, Calwerstrasse 7, 72076, Tübingen, Germany.
Jiri SonekFetal Medicine Foundation USA, Dayton, OH, USA.
Markus HoopmannDepartment of Women's Health, University of Tuebingen, Calwerstrasse 7, 72076, Tübingen, Germany.
Natalia ProdanDepartment of Women's Health, University of Tuebingen, Calwerstrasse 7, 72076, Tübingen, Germany.
Gertruda JonaityteDepartment of Women's Health, University of Tuebingen, Calwerstrasse 7, 72076, Tübingen, Germany.
Tania ElgerDepartment of Women's Health, University of Tuebingen, Calwerstrasse 7, 72076, Tübingen, Germany.
Karl Oliver KaganDepartment of Women's Health, University of Tuebingen, Calwerstrasse 7, 72076, Tübingen, Germany. KOKagan@gmx.de.ORCID 0000-0003-1497-5143
University of Tübingen · DEWright State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effect of the presence or absence of fetal anomalies and soft markers diagnosed by ultrasound on positive predictive value (PPV) 21, 18 and 13 in pregnancies with a high-risk cfDNA result.

methodsRetrospective study including singleton pregnancies with high-risk NIPT results for common trisomies followed by invasive testing. The cases were grouped by gestational age at the time of invasive testing and by the presence or absence of fetal abnormalities or soft markers. The ultrasound was considered abnormal if at least one major defect or a soft marker was detected.

resultsA total of 173 women were included. Median maternal and gestational age was 37.7 years and 14.0 weeks, respectively. CfDNA test result showed high-risk for trisomy 21 and trisomy 18 or 13 in 119 and 54 cases, respectively. The "pre-ultrasound" PPV for trisomy 21 and for trisomy 18 or 13 were 98.3% and 68.4%, respectively. In case of a high-risk result for trisomy 21 and no fetal anomalies, the PPV was 86.7% while it was 100% if there were anomalies or markers present. In the case of a high-risk result for trisomy 18 or 13, the PPV was 9.5% if the ultrasound examination was normal and 100% if the ultrasound examination was abnormal.

conclusionThis study suggests that a detailed ultrasound examination performed after a cfDNA result that is high-risk for one of the common autosomal trisomies adds significantly to establishing an individualized risk assessment. This is particularly true in cases with a high-risk result for trisomies 18 or 13.

Indexed as

Down SyndromeTrisomy 13 SyndromeTrisomy 18 SyndromeUltrasonography, PrenatalAdultCell-Free Nucleic AcidsFemaleGestational AgeHumansNoninvasive Prenatal TestingPredictive Value of TestsPregnancyRetrospective StudiesTrisomyCell-Free Nucleic AcidscfDNAFetal defectsNIPTTrisomyUltrasound examination

Identifiers

PMID38091054
PMCPMC11258052
OpenAlexW4389684625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.